Suppr超能文献

CDH1 基因多态性与胃癌风险的关联:基于 44 项研究的荟萃分析。

Associations between CDH1 gene polymorphisms and the risk of gastric cancer: A meta-analysis based on 44 studies.

机构信息

Department of Gastroenterology, Weifang People's Hospital, The First Affiliated Hospital of Weifang Medical University, Weifang, Shandong, China.

School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong, China.

出版信息

Medicine (Baltimore). 2024 Jun 7;103(23):e38244. doi: 10.1097/MD.0000000000038244.

Abstract

BACKGROUND

Numerous studies have investigated the association between CDH1 polymorphisms and gastric cancer (GC) risk. However, the results have been inconsistent and controversial. To further determine whether CDH1 polymorphisms increase the risk of GC, we conducted a meta-analysis by pooling the data.

METHODS

Relevant case-control studies were collected from PubMed, Embase, Web of Science and Cochrane databases up to January 7, 2024. Subsequently, odds ratios (ORs) with 95% confidence intervals (CIs) were used to evaluate the strength of correlations. A sensitivity analysis was performed to evaluate the robustness and reliability of these included studies.

RESULTS

A total of 25 articles including 44 studies, were included in this meta-analysis, including 26 studies on rs16260, 6 studies on rs3743674, 7 studies on rs5030625, and 5 studies on rs1801552. The pooled results showed that rs16260 was remarkably associated with an increased GC risk of GC among Caucasians. Moreover, the rs5030625 variation dramatically enhanced GC predisposition in the Asian population. However, no evident correlations between CDH1 rs3743674 and rs1801552 polymorphisms and GC risk were observed.

CONCLUSIONS

Our findings suggested that CDH1 gene polymorphisms were significantly correlated with GC risk, especially in rs16260 and rs5030625 polymorphisms.

摘要

背景

许多研究调查了 CDH1 多态性与胃癌(GC)风险之间的关联。然而,结果不一致且存在争议。为了进一步确定 CDH1 多态性是否会增加 GC 的风险,我们进行了荟萃分析以汇总数据。

方法

从 PubMed、Embase、Web of Science 和 Cochrane 数据库中收集截至 2024 年 1 月 7 日的相关病例对照研究。随后,使用比值比(ORs)及其 95%置信区间(CIs)来评估相关性的强度。进行敏感性分析以评估这些纳入研究的稳健性和可靠性。

结果

这项荟萃分析共纳入了 25 篇文章,包含 44 项研究,其中包括 26 项关于 rs16260 的研究、6 项关于 rs3743674 的研究、7 项关于 rs5030625 的研究和 5 项关于 rs1801552 的研究。汇总结果表明,rs16260 与高加索人群的 GC 风险显著相关。此外,rs5030625 变异显著增加了亚洲人群的 GC 易感性。然而,CDH1 rs3743674 和 rs1801552 多态性与 GC 风险之间没有明显的相关性。

结论

我们的研究结果表明,CDH1 基因多态性与 GC 风险显著相关,尤其是 rs16260 和 rs5030625 多态性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89f5/11155553/48906ff3316d/medi-103-e38244-g001.jpg

相似文献

1
Associations between CDH1 gene polymorphisms and the risk of gastric cancer: A meta-analysis based on 44 studies.
Medicine (Baltimore). 2024 Jun 7;103(23):e38244. doi: 10.1097/MD.0000000000038244.
2
CDH1 gene polymorphisms, plasma CDH1 levels and risk of gastric cancer in a Chinese population.
Mol Biol Rep. 2012 Aug;39(8):8107-13. doi: 10.1007/s11033-012-1658-0. Epub 2012 Apr 26.
3
Association of genetic variants in and promoter hypermethylation of CDH1 with gastric cancer: a meta-analysis.
Medicine (Baltimore). 2014 Oct;93(19):e107. doi: 10.1097/MD.0000000000000107.
4
The E-cadherin (CDH1) -160C>A polymorphism associated with gastric cancer among Asians but not Europeans.
DNA Cell Biol. 2011 Jun;30(6):395-400. doi: 10.1089/dna.2010.1091. Epub 2011 Jan 8.
5
CDH1 -160C>A gene polymorphism is an ethnicity-dependent risk factor for gastric cancer.
Cytokine. 2011 Aug;55(2):266-73. doi: 10.1016/j.cyto.2011.04.008. Epub 2011 May 12.
7
Roles of E-cadherin (CDH1) genetic variations in cancer risk: a meta-analysis.
Asian Pac J Cancer Prev. 2014;15(8):3705-13. doi: 10.7314/apjcp.2014.15.8.3705.
9
Gene rs1801552 C/T Polymorphism Increases Susceptibility to Esophageal Squamous Cell Carcinoma but Not to Gastric Cardiac Adenocarcinoma.
Cancer Invest. 2021 Nov;39(10):812-818. doi: 10.1080/07357907.2021.1916520. Epub 2021 Oct 8.
10
The roles of IL-6, IL-8 and IL-10 gene polymorphisms in gastric cancer: A meta-analysis.
Cytokine. 2018 Nov;111:230-236. doi: 10.1016/j.cyto.2018.08.024. Epub 2018 Sep 6.

本文引用的文献

1
Cancer statistics, 2024.
CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49. doi: 10.3322/caac.21820. Epub 2024 Jan 17.
2
, Homologous-Recombination Genes, and Gastric Cancer.
N Engl J Med. 2023 Mar 30;388(13):1181-1190. doi: 10.1056/NEJMoa2211807.
5
Targeting Gastric Cancer Stem Cells to Enhance Treatment Response.
Cells. 2022 Sep 10;11(18):2828. doi: 10.3390/cells11182828.
6
Methylation and Polymorphism in CDH1 Gene Promoter Among Patients with Diffuse Gastric Cancer.
Int J Prev Med. 2022 Mar 12;13:44. doi: 10.4103/ijpvm.IJPVM_288_20. eCollection 2022.
7
CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer.
Br J Cancer. 2022 Mar;126(5):797-803. doi: 10.1038/s41416-021-01673-7. Epub 2021 Dec 23.
8
Association of CDH1 -160 C → A and -347 G→ GA polymorphisms and expression of E-cadherin and gastric cancer: A case-control study.
Turk J Surg. 2021 Mar 22;37(1):41-48. doi: 10.47717/turkjsurg.2021.5097. eCollection 2021 Mar.
9
Correlation of -160C > A and -347GA > G polymorphisms in E-cadherin gene and gastric cancer in north of Iran.
J Res Med Sci. 2021 Jan 28;26:3. doi: 10.4103/jrms.JRMS_50_20. eCollection 2021.
10
Gene rs1801552 C/T Polymorphism Increases Susceptibility to Esophageal Squamous Cell Carcinoma but Not to Gastric Cardiac Adenocarcinoma.
Cancer Invest. 2021 Nov;39(10):812-818. doi: 10.1080/07357907.2021.1916520. Epub 2021 Oct 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验